Press Release

CD BIOSCIENCES LAUNCHES SUBSTRATE-CHROMOGENS FOR IMMUNOHISTOCHEMISTRY



CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry

FOR IMMEDIATE RELEASE

23/01/2024

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has announced the launch of its innovative line of Chromogenic Substrates for immunohistochemistry (IHC). These cutting-edge substrates offer superior signal sensitivity, long-term storage stability, enhanced safety, and user-friendliness, empowering researchers to unlock deeper insights into protein expression and function within tissues.

Immunohistochemistry is the study of the localization, characterization, and relative quantification of peptides and proteins in tissue cells using the antigen-antibody reaction, in which an antigen specifically binds to an antibody and a chemical reaction results in the visualization of dyes such as fluorescein and other chromogens, as well as enzymes, metal ions and isotopes, and other chemicals that label the antibody.

IHC has a wide range of applications. For instance, it is widely used to diagnose abnormal cells, such as those found in cancerous tumors, by using specific molecular markers to characterize specific cellular events, such as proliferation or cell death (apoptosis). Additionally, IHC is widely used to understand the distribution and localization of biomarkers and differentially expressed proteins in different parts of biological tissues. Recognizing the wide range of applications for IHC, CD BioSciences has developed a variety of chromogenic substrates, each with high signal sensitivity, to provide customers with a research tool that is stable for long-term storage, sensitive, safe and easy to use.

For example, the HRP Blue Plus Substrate-Chromogen Kit (Catalog NO: SCI020108) is designed for use with peroxidase detection systems and allows the detection of cellular antigens or nucleic acids in paraffin-embedded tissues, cryostat sections, cytosmears, and cell preparations. The substrate chromogen is the final step in the detection process, allowing the antibody-antigen complex to be viewed under a light microscope. This occurs because HRP Yellow acts as an electron donor in the presence of the enzyme horseradish peroxidase. HRP Yellow is oxidized and produces a yellow color at the site of the target antigen or nucleic acid. It is particularly useful for dual staining or multiplex IHC or CISH applications.

For HRP Detection Systems, the ready-to-use ALK Blue Substrate-Chromogen (Catalog NO: SCI020201) is suitable for use in immunohistochemical, immunocytochemical, and in situ hybridization procedures utilizing alkaline phosphatase detection systems. It is for in vitro diagnostic use only and is not intended for use in humans or animals.

CD BioSciences is committed to advancing IHC technology and empowering researchers with the tools they need to make breakthrough discoveries. The dedicated team of scientists at CD BioSciences has developed these next-generation substrates to overcome a variety of challenges and provide researchers with a powerful tool for deciphering the complex language of proteins in tissues.

CD BioSciences chromogenic substrates are specifically designed to elevate tissue analysis to new heights. For further information, please visit https://www.bioimagingtech.com/substrate-chromogens-for-immunohistochemistry.html.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.

Tags:
chromogenic substrates  |  CD BioSciences  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.